Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events icpe all access 2020
… about your product. Our pharmacoeconomics experts, nearly all of them PhD- or masters-level researchers, can help you: …
… Mond T, Marshall G, Sweeney C, Davenport E, Wang J. @AANP_NEWS #AANP23 …
… the literature for a targeted topic of interest. Review of all the literature in a particular disease area, drug, or … clinical development programs. Incidence of adverse events among a patient population or those taking a certain drug. Review of all information (prevalence, symptoms, health care …
International Symposium on Merkel Cell Carcinoma (ISMCC 2022) Share on: Monday, April 25, 2022 Conference Website Research coauthored by RTI-Health Solutions researcher Alejandro Vanegas will be presented at the International Symposium on Merkel Cell …
… Adverse Cardiac Events in COPD Patients Treated with Inhaled Bronchodilators … infarction, stroke, and other major adverse cardiac events in new users of aclidinium, aclidinium/formoterol, and …
Josephine Mauskopf Recognized by ISPOR For Extraordinary Leadership Share on: April 16, 2019 The International Society for Pharmacoeconomics and Outcomes Research ( ISPOR ) announced yesterday that it had recognized Josephine Mauskopf, PhD, Vice …
14th Annual Sentinel Initiative Public Workshop Share on: Tuesday, November 15 - Wednesday, November 16, 2022 Event webpage Bradley Layton, PhD, Director, Epidemiology at RTI Health Solutions is giving a presentation at the 14th Annual Sentinel …
… MEd, MA Head, Economic QUalitative Inquiry, Policy, and Access RTI Health Solutions This is part two of a three-part … products and services are accessible and beneficial to all people, irrespective of race, ethnicity, gender identity, … innovation. Understanding and prioritizing the needs of all patients rather than only certain groups can yield new …
… by: Anne Heyes, MBA Vice President, Head of Value & Access, Europe RTI Health Solutions United States Inflation … be introduced in January 2028. And finally, regulation for all new medicines will start in January 2030. This has left … aim to bring standardization and greater equity to HTAs to all EU member countries. The EU has proposed a sweeping …
… Clinical Trials With broad therapeutic experience across all phases of clinical development, we can provide a complete … to help achieve your product development and market access objectives. QoL Analyses Patient-centered outcomes and …